Copyright Reports & Markets. All rights reserved.

Global and China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Type
    • 1.4.2 AMG-228
    • 1.4.3 BMS-986156
    • 1.4.4 FPA-154
    • 1.4.5 GWN-323
    • 1.4.6 INCAGN-1876
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Application
    • 1.5.2 Melanoma
    • 1.5.3 Non-Small Cell Lung Cancer
    • 1.5.4 Gastric Cancer
    • 1.5.5 Blood Cancer
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, Estimates and Forecasts
    • 2.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2015-2026
    • 2.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2015-2026
  • 2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2021-2026)

3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Competitor Landscape by Players

  • 3.1 Global Top Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers
    • 3.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers by Revenue
    • 3.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue in 2019
    • 3.2.5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturers
  • 3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base Distribution, Product Types
    • 3.4.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
    • 3.4.3 Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 18 Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Type (2015-2020)
    • 4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020)
    • 4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2015-2020)
    • 4.1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2021-2026)
    • 4.2.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Application (2015-2020)
    • 5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020)
    • 5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2015-2020)
    • 5.1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2015-2020)
  • 5.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
    • 6.1.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales YoY Growth 2015-2026
    • 6.1.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue YoY Growth 2015-2026
    • 6.1.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share in Global Market 2015-2026
  • 6.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Players (International and Local Players)
    • 6.2.1 China Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players by Sales (2015-2020)
    • 6.2.2 China Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players by Revenue (2015-2020)
  • 6.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Review by Type (2015-2020)
    • 6.3.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
    • 6.3.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2015-2020)
  • 6.4 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2021-2026)
    • 6.4.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Type (2021-2026)
  • 6.5 China Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Review by Application (2015-2020)
    • 6.5.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
    • 6.5.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2015-2020)
  • 6.6 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2021-2026)
    • 6.6.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
  • 7.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
    • 7.2.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2015-2020)
    • 7.2.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
  • 8.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
    • 8.2.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
    • 8.2.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
  • 10.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
    • 10.2.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
    • 10.2.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
    • 11.2.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Ablynx NV
    • 12.1.1 Ablynx NV Corporation Information
    • 12.1.2 Ablynx NV Description and Business Overview
    • 12.1.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.1.5 Ablynx NV Recent Development
  • 12.2 Amgen Inc
    • 12.2.1 Amgen Inc Corporation Information
    • 12.2.2 Amgen Inc Description and Business Overview
    • 12.2.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.2.5 Amgen Inc Recent Development
  • 12.3 Apogenix GmbH
    • 12.3.1 Apogenix GmbH Corporation Information
    • 12.3.2 Apogenix GmbH Description and Business Overview
    • 12.3.3 Apogenix GmbH Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.3.5 Apogenix GmbH Recent Development
  • 12.4 Bristol-Myers Squibb Company
    • 12.4.1 Bristol-Myers Squibb Company Corporation Information
    • 12.4.2 Bristol-Myers Squibb Company Description and Business Overview
    • 12.4.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.4.5 Bristol-Myers Squibb Company Recent Development
  • 12.5 Five Prime Therapeutics Inc
    • 12.5.1 Five Prime Therapeutics Inc Corporation Information
    • 12.5.2 Five Prime Therapeutics Inc Description and Business Overview
    • 12.5.3 Five Prime Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.5.5 Five Prime Therapeutics Inc Recent Development
  • 12.6 Incyte Corp
    • 12.6.1 Incyte Corp Corporation Information
    • 12.6.2 Incyte Corp Description and Business Overview
    • 12.6.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.6.5 Incyte Corp Recent Development
  • 12.7 MedImmune LLC
    • 12.7.1 MedImmune LLC Corporation Information
    • 12.7.2 MedImmune LLC Description and Business Overview
    • 12.7.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.7.5 MedImmune LLC Recent Development
  • 12.8 Merck & Co Inc
    • 12.8.1 Merck & Co Inc Corporation Information
    • 12.8.2 Merck & Co Inc Description and Business Overview
    • 12.8.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.8.5 Merck & Co Inc Recent Development
  • 12.9 Novartis AG
    • 12.9.1 Novartis AG Corporation Information
    • 12.9.2 Novartis AG Description and Business Overview
    • 12.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.9.5 Novartis AG Recent Development
  • 12.10 OncoMed Pharmaceuticals Inc
    • 12.10.1 OncoMed Pharmaceuticals Inc Corporation Information
    • 12.10.2 OncoMed Pharmaceuticals Inc Description and Business Overview
    • 12.10.3 OncoMed Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.10.5 OncoMed Pharmaceuticals Inc Recent Development
  • 12.11 Ablynx NV
    • 12.11.1 Ablynx NV Corporation Information
    • 12.11.2 Ablynx NV Description and Business Overview
    • 12.11.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
    • 12.11.5 Ablynx NV Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Tumor Necrosis Factor Receptor Superfamily Member 18 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Receptor Superfamily Member 18 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented into
    AMG-228
    BMS-986156
    FPA-154
    GWN-323
    INCAGN-1876
    Others

    Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented into
    Melanoma
    Non-Small Cell Lung Cancer
    Gastric Cancer
    Blood Cancer
    Others

    Regional and Country-level Analysis
    The Tumor Necrosis Factor Receptor Superfamily Member 18 market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Tumor Necrosis Factor Receptor Superfamily Member 18 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share Analysis
    Tumor Necrosis Factor Receptor Superfamily Member 18 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tumor Necrosis Factor Receptor Superfamily Member 18 business, the date to enter into the Tumor Necrosis Factor Receptor Superfamily Member 18 market, Tumor Necrosis Factor Receptor Superfamily Member 18 product introduction, recent developments, etc.
    The major vendors covered:
    Ablynx NV
    Amgen Inc
    Apogenix GmbH
    Bristol-Myers Squibb Company
    Five Prime Therapeutics Inc
    Incyte Corp
    MedImmune LLC
    Merck & Co Inc
    Novartis AG
    OncoMed Pharmaceuticals Inc
    Regeneron Pharmaceuticals Inc

    Buy now